DUBLIN–(BUSINESS WIRE)–The “Diabetes Devices Market By Type (BGM Devices, Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By Distribution Channel, By End User, and by Region – Global Forecast to 2023-2033” report has been added to ResearchAndMarkets.com’s offering.
The diabetes devices market size is estimated to be USD 28.45 billion in 2022 and is expected to witness a CAGR of 8.02% during the forecast period 2023-2033.
Companies Mentioned
F. Hoffmann-La-Ltd.
Medtronic plc
Lifescan Inc.
Novo Nordisk
Abbott Laboratories
B Braun Melsungen AG
Lifescan Inc.
Insulet Corporation
Ypsomed Holdings
Dexcom Inc.
Sanofi
Companion Medical
Valeritas Holding Inc.
Arkray Inc.
Growing incidence of diabetes due to aging, obesity, & unhealthy lifestyle, large geriatric population, affordable healthcare facilities, and relatively less stringent regulatory policies are some of the factors contributing to the market growth.
Furthermore, increase in prevalence of new technologically advanced blood glucose monitoring systems, cost-efficient labor, rise in the incidences of obesity, and increasing adoption of insulin delivery devices are other factors supporting the market growth. However, diabetes care devices tend to be quite expensive and challenging to use expected to hinder the growth.
Growing incidence of diabetes due to aging, obesity, & unhealthy lifestyle is expected to fuel the market growth during the forecast period. For instance, in 2021, the International Diabetes Federation (IDF) estimates that 537 million adults worldwide between the ages of 20 and 79 will have diabetes.
Increase in prevalence of new technologically advanced blood glucose monitoring systems is expected to propel the market growth during the forecast period. For instance, in March 2021, the new Accu-Check Instant system, which features Bluetooth connectivity to the mySugr app and transmits blood glucose data to the mySugr app was introduced by Roche. This method helps the business’s patient-centered treatment approach to provide customised diabetes care.
Market Segmentation:
By Type (Revenue, USD Million), 2022 – 2033
BGM Devices
Self-Monitoring Devices
Lancets
Testing Strips
Blood Glucose Meters
Continuous Glucose Monitoring Devices
Receiver
Sensors
Transmitters
Insulin Delivery Devices
Pens
Syringes
Pumps
Jet Injectors
By Distribution Channel (Revenue, USD Million), 2022 – 2033
Retail Pharmacies
Hospital pharmacies
Online Pharmacies
Diabetes Clinics/Centers
By End User (Revenue, USD Million), 2022 – 2033
Homecare
Diagnostic Centers
Hospitals
By Region (Revenue, USD Million), 2022 – 2033
North America
U.S.
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/i0pjm7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900